Ori Biotech, a prominent entity based in London and New Jersey, leads in cell and gene therapy (CGT) manufacturing technology. This organization has created a proprietary, full-stack manufacturing ...

Accelerated approval relies on cornstarch-reduction as a surrogate endpoint, with crossover follow-up planned at 96 and 144 ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This voice experience is generated by AI. Learn more. This ...

StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models. Gene therapy can effectively treat various ...

U.S. market projected to reach $10.28 billion and Europe $8.57 billion by 2035 as biopharma outsourcing, viral-vector demand, ...

TOKYO--(BUSINESS WIRE)--PHC Corporation Biomedical Division (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura, hereinafter referred to as "Biomedical Division") will showcase a prototype ...

One of the more exciting opportunities in medical technology is using a virus to carry genetic information in the form of DNA and RNA in the cells. One of the most commonly used viruses is ...

Vertex Pharmaceuticals (NASDAQ:VRTX) stock drew attention as gene therapy sales climbed and an expanded approval broadened ...

GJB2 gene therapy enters human testing for the first time as Skylark Bio doses the first child in the SONIX Phase 1/2 trial, ...

Ladies and gentlemen, thank you for standing by. Welcome to PTC Therapeutics' Fabry Disease Transaction Call. [Operator Instructions] Please be advised that today's conference is being recorded. I ...

Doctors have long debated how to balance the need for safety in gene therapy trials with the urgency of developing treatments ...